Solid biosciences to present at svb securities global biopharma conference

Charlestown, mass., feb. 08, 2023 (globe newswire) -- solid biosciences inc. (nasdaq: sldb), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that bo cumbo, president and chief executive officer, will present at the svb securities global biopharma conference on wednesday, february 15, 2023, at 1:40 pm et.

SLDB Ratings Summary

SLDB Quant Ranking